SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001654954-19-008322
Filing Date
2019-07-17
Accepted
2019-07-17 16:57:35
Documents
2

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT azrx424b5.htm 424B5 670336
2 IMAGE azurrx.jpg GRAPHIC 4352
  Complete submission text file 0001654954-19-008322.txt   677518
Mailing Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226
Business Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226 646-699-7855
AzurRx BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 424B5 | Act: 33 | File No.: 333-231954 | Film No.: 19959593
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1